ENDPOINTS

FDA raises issues with four cancer drugs ahead of adcomm

The FDA on Friday raised efficacy, safety and trial design issues surrounding three new cancer drug indications and one new cancer drug ahead of a two-day meeting of its Oncologic Drugs Advisory Committee next week ...

May 16, 2025 - 18:44
 0
FDA raises issues with four cancer drugs ahead of adcomm
The FDA on Friday raised efficacy, safety and trial design issues surrounding three new cancer drug indications and one new cancer drug ahead of a two-day meeting of its Oncologic Drugs Advisory Committee next week ...
Read More

Tags:

Previous Article

Rare two-headed snake is surprisingly thriving

Next Article

Scientists solve mystery of how orange cats got their coats — and why so many ar...

Related Posts

Aldeyra plots third FDA filing for dry eye disease drug after latest Phase 3 data

Aldeyra plots third FDA filing for dry eye disease drug...

May 6, 2025  0

Advocacy groups and experts call for decade-long ban on germline editing

Advocacy groups and experts call for decade-long ban on...

May 14, 2025  0

Sarepta seeks to expand Duchenne gene therapy Elevidys use to toddlers

Sarepta seeks to expand Duchenne gene therapy Elevidys ...

May 16, 2025  0